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Introduction
Malaria is a mosquito borne parasitic disease of the blood caused by 
a Protozoan belonging to the genus Plasmodium. It is considered the 
most prevalent infectious disease in the world. According to the World 
Health Organization and the World Malaria Report of 2018 , there were 
an estimated 219 million cases of malaria and 435 000 related deaths 
in 2017, compared with 217 million cases in 2016 which highlight the 
need for a new effective drugs against malaria.1 Malaria is caused by 
different species of Plasmodium, of which P. falciparum is the most 
virulent human malaria parasite, contributing to 90% of total malarial 
deaths.2,3 The life cycle of Plasmodium species is complex. During 
the intra-erythrocytic stage, the Plasmodium feeds on the hemoglobin 
of the hosts RBC’s.4 Active metabolism of hemoglobin takes place 
in an acidic lysosome-like organelle called the food vacuole that has 
a pH of about 5.0 to 5.4.5–8 Large amounts of free heme known as 
ferriprotoporphyrin (IX) (FePPIX) are released.9,10 The accumulation 
of ferriprotoporphyrin (IX) causes the generation of reactive oxygen 
species which may induce oxidative stress leading to parasitic death.11 
However, plasmodium parasite acquired a unique detoxification 
method of free heme through its conversion into a non-toxic, inert, 
insoluble, crystalline and black-brown pigment called hemozoin.12
β-Hematin crystals (hemazoin) are made of dimer of hematin 
molecules that are oxygen coordinate bond links the central iron 
of one hematin to the oxygen of the carboxylate side-chain of the 
adjacent hematin.13 Many clinically used antimalarial drugs such 
as chloroquine and amodaquine are thought to act by inhibiting 
the formation of hemozoin in the food vacuole. This prevents the 
detoxification of the heme released in this compartment, and kills 
the parasite.14 Through the years, quinoline-ring based drugs such as 
chloroquine have proved their effectiveness as antimalarial drugs by 
accumulating inside the food vacuoles of the parasite preventing the 
formation of hemozoin, killing the parasite.15,16 Recently strains of 
plasmodium falciparum formed resistance to Chloroquine, drawing 
attention to discover novel antimalarial candidates. Curcuma longa 
(turmeric) has a long history of use to treat inflammatory conditions.17 
It is the major source of the active polyphenol, curcumin. Extensive 
research over the past half century has displayed that curcumin can 
modulate multiple cell signaling pathways.18,19 More recently, the in 
vivo antiplasmodial activity of curcuminoids was evaluated.20 This 
research, however, aimed to explore the inhibitory effect of different 
natural curcuminod isolates including curcumin analytical standard 
on β-hematin using semi-quantitative and quantitative screening 
methods. 
Materials and methods
HPLC grade solvents of acetonitrile (ACN) and water (H2O), 
dimethyl sulfoxide (DMSO), chloroquine diphosphate salt (CQ), 
amodiaquine hydrochloride (AD), curcumin analytical standard (98% 
by HPLC), sodium acetate, and hemin chloride were all purchased 
from Sigma-Aldrich. Ethanol (EtOH) was from Merck (Germany), 
and glacial acetic acid was from Fluka. Organic ground turmeric 
root powder (Bonomolli, Italy) was bought from a local market in 
Jerusalem.
Preparation of turmeric extract
Two grams of fine-powdered organic ground turmeric was soaked 
in 150ml of absolute ethanol 99.5%, left for about 24 h at room 
temperature and then filtered using MN 615.Ø110mm filter paper. 
The resultant extract was evaporated using (IKA WEREK RV06-ML) 
rotary evaporator at 55-60°C under reduced pressure. Then, it was 
lyophilized using Labconco freeze drier (USA), until constant weight 
was achieved. The final dried extract was stored in an amber bottle 
and kept in the fridge.
Semi-quantitative in-vitro Method
According to Deharo assay,21 a mixture containing of 50μL of 
0.5mg/ml hemin chloride freshly dissolved in dimethyl sulphoxide 
(DMSO), 100μL of 0.5 M sodium acetate buffer (pH 4.4), and 50μL 
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Abstract
Natural curcuminod isolates from turmeric Curcuma longa that belongs to ginger 
family Zingiberaceae were collected using reversed phase preparative HPLC coupled to 
photodiode array detector and their in-vitro effect on β-hematin inhibition were explored. 
Turmeric ethanolic crude extract was ten-fold less active in comparison to chloroquine 
positive control. Moreover, semi-quantitative and quantitative analysis results revealed 
that curcumin analytical standard, and to a lesser extent, the turmeric three natural isolates 
impeded β-hematin formation in a relatively comparable extent to chloroquine and 
amodiaquine positive controls. This result unequivocally indicates the key role curcumin 
active ingredient plays as an inhibitor of β-hematin formation. Edible turmeric root powder 
is commercially available and safe to use.
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of the tested potential anti-malarial drug solution or control, was 
incubated in a normal non-sterile 96-well flat bottom plate at 37ºC for 
18-24 h. It is important that the solutions be added to the plate in this 
order. The plate was then centrifuged for 10 minutes at 4000rpm. The 
supernatant was removed and the pH of reaction was measured. The 
final pH of the mixture should be between (5.0-5.2). The wells were 
washed with 200μl DMSO per well to remove free hemin chloride. The 
plate was centrifuged again, discharging the supernatant afterwards. 
The β-hematin remaining was then dissolved in 200μl of 0.1 M NaOH 
to form an FP that can be measured spectrophotometrically. Finally 
the absorbance was read at 405nm using ELISA reader.
Quantitative method 
According to Blauer & Akkawi22 method, a freshly prepared 
stock solution of hemin chloride was prepared by dissolving the salt 
in dimethyl sulfoxide and incubated for 30 minutes at 30°C; stock 
solution of curcumin dissolved in 0.02N NaOH prepared. A 0.5 
M of sodium acetate buffer (pH 4.4) was also prepared. The final 
concentration of hemin and the complex in the reaction were 0.2 
and 0.4 mM respectively. The whole mixture was left for 18-24h at 
37°C without stirring. The total volume of the reaction mixture was 
32mL, and the final pH was 4.9-5.2.Samples were centrifuged for 
10min using a serological (JouanB4) centrifuge. The supernatant was 
discarded and the precipitate was washed with ultrapure water and 
quantitatively transferred to a Millipore Swinnex 13 filter containing 
Whatman filter paper No. 50, already lyophilized to a constant weight 
in freeze-drying machine (Labconco Freezone). DMSO was passed 
slowly through the filter until the filtrate remained feebly colored 
and washed again with ultra-pure water. The remaining was then 
lyophilized to a constant weight.
Chromatographic conditions
Fresh 400mg turmeric extract was dissolved with 40ml 0f 
(EtOH:H2O; 3:1; V:V), giving rise to a very clear orange solution. 
Filtration through 0.46μm PTFE disposable membrane brings about 
a solution of 10mg/ml concentration. Small concentration was 
chosen to permit base-line separation of the structurally related 
turmeric compounds and therefore to collect pure isolates. One ml 
(1000μl) was injected at flow of 20ml/min using gradient mixture 
of acetonitrile ACN and H2O. First, a 45% of ACN was chosen and 
then raised linearly to 70% in 13 minutes. The percentage increased 
then to 100% in one minute and hold constant for 5 minutes to clean 
the column. Finally, the percentage was decreased back to 45% ACN 
in one minute. The column equilibration time was set for 5 minutes 
before injection new sample.
Results and discussion
Preparative HPLC of turmeric extract
Turmeric extract contains major three curcuminoids, namely, 
bisdemethoxycurcumin (a), demethoxycurcumin (b) and curcumin 
(c) which is responsible for its yellow color (Figure 1). These 
curcuminoids are structurally related; therefore, their separation 
with satisfactory resolution is considered a challenge. The polarity 
order of the compounds is as follows: (a) > (b) > (c). Consequently, 
as expected, (a) eluted first while (c) eluted last in reversed phase 
chromatography mode. Figure 2 and Figure 3 shows the preparative 
chromatographic peaks profile of the major three close-by eluted 
curcuminoids and turmerones at wavelengths of 425 and 245nm 
respectively. The overlaid UV-VIS spectra from 200-600nm using the 
photodiode array detector are seen in the same figures. 
Figure 1 Chemical structures of the main curcuminoids in ethanolic extract, 
bisdemethoxycurcumin (a), demethoxycurcumin (b) and curcumin (c).
Figure 2 Preparative HPLC-PDA chromatogram of crude curcumin dissolved in 100% ethanol at 420 nm.
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Figure 3 Preparative HPLC-PDA chromatogram of crude curcumin dissolved in 100% ethanol at 240 nm.
Phytochemical curcuminoid (a), which eluted first, showed 
maximum adsorption at 416.1nm (red, retention of 13.83 minutes), 
while (b) exhibited maximum absorption at 420.9nm (blue, retention 
of 14.18 minutes) while curcuminoid (c) showed maximum absorption 
at 423.3nm (green, retention of 14.54 minutes). Satisfactory resolution 
between the three compounds were enabled us to isolate relatively 
pure isolates of each compound. As seen in Figure 3, turmerones 
eluted at longer retention time and monitored at a wavelength of 
240nm. According to their UV spectrum and mass spectrometric data, 
most probably, the ar-turmerone, α and β-tumerone eluted at 24.43, 
29.17 and 29.54 minutes respectively.23
Semi-quantitative method
Results of the in-vitro semi-quantitative experiments on pure 
curcumin analytical standard and crude turmeric extract along with 
individual isolates of curcuminoid (designated as F1, F2 and F3) 
are depicted in Figure 4 and Figure 5 respectively. The antimalarial 
efficiency was evaluated from the absorption of β-haematin at 405nm 
of the turmeric ethanolic extract in comparison to water and NaOH 
negative control and chloroquine positive control (CQ-0.1mg/ml). 
Absorption is inversely proportional to extract efficiency and to 
hemozoin content. As in Figure 4, pure curcumin analytical standard 
showed high activity as revealed from its absorption value (0.146 
at 0.1mg/ml) in comparison to (0.107 at 0.1mg/ml) value of the 
CQ positive control. When the concentration of curcumin standard 
increased five folds (0.5mg/ml), the antimalarial activity increased 
low below the chloroquine positive control. 
Figure 4 Column diagram representing the efficacy of curcumin analytical standard dissolved in 0.02N NaOH compared to water and 0.02 N NaOH solution 
negative controls and chloroquine (CQ-0.1mg/ml) positive control, showing the absorption values of dissolved β-hematin (alkaline hematin) at 405 nm using 
ELISA reader. Each result represents the average of 16 individual experiments.
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Figure 5 Column diagram representing the efficacy of β-hematin inhibition of crude turmeric extract (dissolved in DMSO) and curcuminoid pure isolate 
fractions, (F1 Bisdemethoxycurcumin of 0.1mg/ml), (F2 demethoxycurcumin of 0.1mg/ ml) and (F3 Curcumin, 0.1mg/ml) dissolved in 0.02 N NaOH compared to 
chloroquine (CQ), amodiaquine (AD) positive controls (0.1 mg/ml), while water and DMSO were used as negative controls. Each result represents an average 
of 16 individual experiments.
When a crude turmeric extract was examined, the activity 
decreased 10 fold compared to positive controls of chloroquine and 
amodiaquine. In the contrary, relatively pure isolates gave adequate 
inhibitory results in the following order: F3>F2>F1 (Figure 5). The 
structural features of the three isolates demonstrate that the addition 
of methyl ether linkage increased activity and therefore played a key 
role on the inhibition of β-haematin (Figure 1). Comparing analytical 
curcumin standard activity with F1 isolate showed small difference in 
favor of curcumin standard. The difference most probably attributed 
to the purity of F1 (92%) compared to curcumin standard (98%).
Quantitative method
The result of curcumin analytical standard compared to DMSO 
negative control and amodiaquine positive control in terms of 
β-hematin formation is depicted in Figure 6 while comparison in 
terms of drug efficiency is seen in Figure 7. As shown in Figure 6, the 
percentage yield of β-hematin formation in the presence of curcumin 
analytical standard and AQ positive control was 21.2% and 8.2% 
respectively. Both active compounds were at concentration 0.4 mM 
comparing to the negative control which was 89.3%. Comparison in 
terms of efficiency of curcumin versus AD positive control is shown 
in Figure 7. Curcumin showed considerable inhibitory effect on 
β-hematin formation with efficiency of 78.8% compared 91.8% of 
AQ and 10.7% for inactive DMSO solvent. Assuming curcuminoid 
isolates act via similar mechanism to chloroquine, to which a complex 
between chloroquine and ferriheme led to the formation of a complex 
which prevent β-hematin formation. Similarly, the interaction of 
ferriheme with curcumin most likely formed by the interaction of 
FeIII metal center with one of the carbonyl group of the curcumin. 
Moreover, the side chain carboxyl group of heme may interact with 
one the hydroxyl groups of curcumin.24, 25
Figure 6 Column diagram representing the percentage yields of curcumin compared to amodiaquine (AD) and DMSO at 0.4 mM. Yields are inversely 
proportional to drugs efficiency, the lower the percentage yield, the better the activity.
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Figure 7 Column diagram representing the efficiency of curcumin compared to amodiaquine (AD) and water at a concentration of 0.4 mM.
Conclusion
Pure isolates from turmeric powder showed promising antimalarial 
activity compared to chloroquine drug in-vitro. Turmeric root powder 
is safe and affordable to everyone besides being used in food recipes. 
Curcumin is a promising active ingredient that does not have the 
disadvantage resistance to malarial paradise as in chloroquine drug.
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